[1] MAKKER V,MACKAY H,RAY-COQUARD I,et al.Endometrial cancer[J].Nat Rev Dis Primers,2021 ,7(1):88. [2] HUSSEN B M,HIDAYAT H J,SALIHI A,et al.MicroRNA:A signature for cancer progression[J].Biomed Pharmacother,2021(138):111528. [3] XU M,TIAN G L,HAO C C,et al.MicroRNA-29 targets FGF2 and inhibits the proliferation,migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway[J].Eur Rev Med Pharmacol Sci,2020,24(13):7199. [4] WANG L H,HUANG J,WU C R,et al.Downregulation of miR-29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer[J].Mol Med Rep,2023,28(3):162. [5] LENG Y,CHEN Z X,DING H,et al.Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis[J].Cancer Cell Int,2021,21(1):17. [6] 唐金舟,毛爱红,廖世奇.miRNA-29b在癌症发生发展中的作用机制及其临床应用的研究进展[J].中国肿瘤生物治疗杂志,2019,26(12):1410-1416. [7] 刘志梅,白洁,吴少群.微小RNA-29b 对卵巢癌细胞生长的抑制作用机制研究[J].中国临床药理学杂志,2021,37(9):1066-1069. [8] 李璟蓉,思远,赵瑞,等.microRNA-29a-3p 对白介素-22诱导的HaCaT细胞增殖的影响研究[J].广州医药,2020,51(3):26-30. [9] ZOU S H,CHEN F,ZHANG L Q,et al.The diagnostic value of circulating miR-29 family for digestive system malignancies:A meta-analysis[J].Lab Med,2024,55(1):1-7. [10] ZHAO J F,MA X Y,XU H Q.miR-29b-3p inhibits 22Rv1 prostate cancer cell proliferation through the YWHAE/BCL-2 regulatory axis[J].Oncol Lett,2022,24(2):289. [11] HUTT S,TAILOR A,ELLIS P,et al.The role of biomarkers in endometrial cancer and hyperplasia:A literature review[J].Acta Oncol,2019,58(3):342-352. [12] DONKERS H,BEKKERS R,GALAAL K.Diagnostic value of microRNA panel in endometrial cancer:A systematic review[J].Oncotarget,2020,11(21):2010-2023. [13] BLOOMFIELD J,SABBAH M,CASTELA M,et al.Clinical value and molecular function of circulating microRNAs in endometrial cancer regulation:A systematic review[J].Cells, 2022,11(11):1836. [14] HE Y,SUN M M,ZHANG G G,et al.Targeting PI3K/Akt signal transduction for cancer therapy[J].Signal Transduct Target Ther,2021,6(1):425. [15] YU L,WEI J,LIU P.Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J].Semin Cancer Biol,2022(85):69-94. [16] MILLER K A,DEGAN S,WANG Y,et al.PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression[J].Oncogene,2024,43(1):22-34. [17] JIA L F,HUANG Y P,ZHENG Y F,et al.MiR-29b suppresses proliferation,migration,and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1[J].Oral Oncol,2014,50(11):1062-1071. [18] ZHANG W Y,WU Q W,LI U Y,et al.LncRNA HOTAIR promotes chemoresistance by facilitating epithelial to mesenchymal transition through miR-29b/PTEN/PI3K signaling in cervical cancer[J].Cells Tissues Organs,2022,211(1):16-29. [19] WANG H Y,GUAN X Y,TU Y S,et al.MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN[J].J Exp Clin Cancer Res,2015,34(1):59. [20] WANG Y,ZHANG T,H E X.Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer[J].Front Oncol,2023(13):1279822. [21] CERAMI E,GAO J,DOGRUSOZ U,et al.The cBio cancer genomics portal:An open platform for exploring multidimensional cancer genomics data[J].Cancer Discov,2012,2(5):401-404. [22] PEREVALOVA A M,KOBELEV V S,SISAKYAN V G,et al.Role of tumor suppressor PTEN and its regulation in malignant transformation of endometrium[J].Biochemistry(Mosc),2022 ,87(11):1310-1326. [23] WU Y,WANG J,GE L N,et al.Significance of a PTEN mutational status-associated gene signature in the progression and prognosis of endometrial carcinoma[J].Oxid Med Cell Longev,2022(2022):5130648. |